SIC
BVS icon

Salem Investment Counselors’s Bioventus BVS Stock Holding History

Salem Investment Counselors’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,375
Closed -$37.5K – 1124
2022
Q4 		$37.5K Sell
14,375
-149,120
-91% -$651K ﹤0.01% 560
2022
Q3 		$1.14M Sell
163,495
-5
-0% -$39 0.05% 162
2022
Q2 		$1.11M Sell
163,500
-71,645
-30% -$731K 0.05% 172
2022
Q1 		$3.32M Buy
235,145
+3,490
+2% +$46.7K 0.13% 103
2021
Q4 		$3.36M Buy
231,655
+5,631
+2% +$80K 0.12% 101
2021
Q3 		$3.2M Buy
226,024
+21,499
+11% +$331K 0.17% 102
2021
Q2 		$3.6M Buy
204,525
+31,225
+18% +$503K 0.2% 99
2021
Q1 		$2.65M Buy
+173,300
New +$2.47M 0.16% 106

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Salem Investment Counselors's BVS Position: Q1 2023 in Review

Salem Investment Counselors sold out of Bioventus (BVS) in Q1 2023, closing a stake of 14,375 shares — an estimated $37.5K sold.

Salem Investment Counselors first reported a position in BVS in Q1 2021 and held it in 8 quarters. The position peaked at $3.6M in Q2 2021. 71 funds tracked by Wall St. Rank hold BVS as of Q1 2023.

  • Salem Investment Counselors reported no remaining Bioventus position as of Q1 2023 after selling out during the quarter.
  • Salem Investment Counselors sold 14,375 Bioventus shares in Q1 2023, an estimated $37.5K.
  • Salem Investment Counselors first reported a position in Bioventus in Q1 2021 and held it in 8 quarters.
  • Salem Investment Counselors's Bioventus position peaked at $3.6M in Q2 2021.
  • 71 funds tracked by Wall St. Rank held Bioventus as of Q1 2023.

Based on Salem Investment Counselors's 13F filing for Q1 2023, filed 11 May 2023.